{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:43:01Z","timestamp":1777794181406,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.nmd.2015.11.009","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T12:37:40Z","timestamp":1448887060000},"page":"136-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Erin M.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahseen","family":"Mozaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Quartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4879-6071","authenticated-orcid":false,"given":"Kenneth I.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2015.11.009_bib0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2015.11.009_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-6-34","article-title":"Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy","volume":"6","author":"Gungor","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2015.11.009_bib0020","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.WNL.0000142597.69707.78","article-title":"Late-onset Pompe disease primarily affects quality of life in physical health domains","volume":"63","author":"Hagemans","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2015.11.009_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nmd.2007.03.006","article-title":"Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale","volume":"17","author":"Hagemans","year":"2007","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2015.11.009_bib0030","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: a prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2015.11.009_bib0035","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2015.11.009_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/ene.12582","article-title":"Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease","volume":"22","author":"Boentert","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2015.11.009_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0960-8966(02)00219-5","article-title":"Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders","volume":"13","author":"Mellies","year":"2003","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2015.11.009_bib0050","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.57.7.1290","article-title":"Sleep-disordered breathing and respiratory failure in acid maltase deficiency","volume":"57","author":"Mellies","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2015.11.009_bib0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/thorax.57.8.724","article-title":"Patterns and predictors of sleep disordered breathing in primary myopathies","volume":"57","author":"Ragette","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.nmd.2015.11.009_bib0060","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1378\/chest.06-1265","article-title":"Lung function accurately predicts hypercapnia in patients with Duchenne muscular dystrophy","volume":"131","author":"Toussaint","year":"2007","journal-title":"Chest Journal"},{"key":"10.1016\/j.nmd.2015.11.009_bib0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/01.wnl.0000251299.54608.13","article-title":"Outcome of noninvasive ventilation in children with neuromuscular disease","volume":"68","author":"Young","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2015.11.009_bib0070","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/thx.2004.037424","article-title":"Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia","volume":"60","author":"Ward","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.nmd.2015.11.009_bib0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1440-1843.2007.01116.x","article-title":"When should home mechanical ventilation be started in patients with different neuromuscular disorders?","volume":"12","author":"Dreher","year":"2007","journal-title":"Respirology"},{"key":"10.1016\/j.nmd.2015.11.009_bib0080","unstructured":"National Government Services I, Local Coverage Determination (LCD): respiratory assist devices (L27228), Services C f M a M, Editor."},{"key":"10.1016\/j.nmd.2015.11.009_bib0085","series-title":"Motor neurone disease: the use of non-invasive ventilation in the management of motor neurone disease","author":"Excellence NIfHaC","year":"2010"},{"key":"10.1016\/j.nmd.2015.11.009_bib0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ymgme.2011.09.012","article-title":"First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease","volume":"104","author":"de Vries","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2015.11.009_bib0095","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0148607189013003321","article-title":"Respiratory insufficiency in acid maltase deficiency: the effect of high protein diet","volume":"13","author":"Demey","year":"1989","journal-title":"JPEN"},{"key":"10.1016\/j.nmd.2015.11.009_bib0100","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00431-013-2258-2","article-title":"Enzyme replacement therapy in juvenile glycogenosis type II: a longitudinal study","volume":"173","author":"Deroma","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.nmd.2015.11.009_bib0105","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1378\/chest.09-1072","article-title":"A 46-year-old man with dyspnea and left diaphragm paralysis","volume":"136","author":"Diab","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.nmd.2015.11.009_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ncn3.66","article-title":"Late-onset Pompe disease after 4 years of enzyme replacement therapy: an autopsy case","volume":"2","author":"Furusawa","year":"2014","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.nmd.2015.11.009_bib0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10545-011-9393-6","article-title":"Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study","volume":"35","author":"Furusawa","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2015.11.009_bib0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ymgme.2013.06.023","article-title":"Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function","volume":"110","author":"Gaeta","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2015.11.009_bib0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2012.12.003","article-title":"Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement","volume":"23","author":"Hobson-Webb","year":"2013","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2015.11.009_bib0130","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00415-014-7402-z","article-title":"Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis","volume":"261","author":"Hundsberger","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2015.11.009_bib0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mus.24142","article-title":"Motor function and respiratory capacity in patients with late-onset pompe disease","volume":"49","author":"Illes","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2015.11.009_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ymgme.2011.05.006","article-title":"Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease","volume":"104","author":"Jones","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2015.11.009_bib0145","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S1388-2457(14)50313-6","article-title":"P173: seven-year follow up of two sisters with late onset Pompe's disease: effects and limitation of enzyme replacement therapy","volume":"125","author":"Kawamoto","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2015.11.009_bib0150","unstructured":"Khan A., McNeil C., Casey R. Improved or stabilized respiratory function in 3 patients with Pompe disease after starting recombinant alpha-glucosidase (rhGAA)-a case to maintain a steady course with treatment. Clin Therap 2010;32:S77."},{"key":"10.1016\/j.nmd.2015.11.009_bib0155","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/jnnp-2013-306573.77","article-title":"Dilative vasculopathy and cerebral haemorrhage as a presentation of late\u2013onset pompe disease","volume":"84","author":"Lilleker","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2015.11.009_bib0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mus.880060306","article-title":"Respiratory improvement by muscle training in adult-onset acid maltase deficiency","volume":"6","author":"Martin","year":"1983","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2015.11.009_bib0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1468-1331.2008.02377.x","article-title":"Glycogen storage disease type II (Pompe disease)\u2013influence of enzyme replacement therapy in adults","volume":"16","author":"Merk","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2015.11.009_bib0170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.braindev.2008.03.007","article-title":"Sleep disordered breathing in childhood-onset acid maltase deficiency","volume":"31","author":"Nabatame","year":"2009","journal-title":"Brain & Development"},{"key":"10.1016\/j.nmd.2015.11.009_bib0175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nmd.2011.04.001","article-title":"Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease","volume":"21","author":"Orlikowski","year":"2011","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2015.11.009_bib0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clineuro.2010.12.005","article-title":"Adult Pompe disease: clinical manifestations and outcome of the first Greek patients receiving enzyme replacement therapy","volume":"113","author":"Papadimas","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nmd.2015.11.009_bib0185","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.nmd.2015.11.009_bib0190","series-title":"Incontinence in Late Onset Pompe disease: an underdiagnosed although potentially treatable condition","author":"Remiche","year":"2011"},{"key":"10.1016\/j.nmd.2015.11.009_bib0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10354-012-0153-5","article-title":"Respiratory function in late-onset Pompe disease patients receiving long-term enzyme replacement therapy for more than 48 months","volume":"163","author":"Schneider","year":"2013","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1016\/j.nmd.2015.11.009_bib0200","doi-asserted-by":"crossref","first-page":"P105","DOI":"10.1055\/s-0032-1301655","article-title":"Respiratory function in late onset Pompe disease patients upon long-term enzyme replacement therapy","volume":"43","author":"Schneider","year":"2012","journal-title":"Klinische Neurophysiologie"},{"key":"10.1016\/j.nmd.2015.11.009_bib0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007611-198702000-00016","article-title":"Respiratory insufficiency in adult-onset acid maltase deficiency","volume":"80","author":"Sivak","year":"1987","journal-title":"South Med J"},{"key":"10.1016\/j.nmd.2015.11.009_bib0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(85)90050-4","article-title":"Adult onset acid maltase deficiency: distribution and progression of clinical and pathological abnormality in a family","volume":"68","author":"Swash","year":"1985","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2015.11.009_bib0215","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2008.04.009","article-title":"Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease","volume":"18","author":"van Capelle","year":"2008","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2015.11.009_bib0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","article-title":"Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease","volume":"19","author":"van der Beek","year":"2009","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2015.11.009_bib0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","article-title":"Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease","volume":"104","author":"van der Beek","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2015.11.009_bib0230","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00408-013-9489-x","article-title":"Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency","volume":"191","author":"Vianello","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.nmd.2015.11.009_bib0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","article-title":"Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up","volume":"55","author":"Winkel","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2015.11.009_bib0240","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","article-title":"Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns","volume":"21","author":"Carlier","year":"2011","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2015.11.009_bib0245","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10545-006-0238-7","article-title":"The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II","volume":"29","author":"Mundy","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2015.11.009_bib0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clineuro.2010.09.016","article-title":"24-months results in two adults with Pompe disease on enzyme replacement therapy","volume":"113","author":"Vielhaber","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nmd.2015.11.009_bib0255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/02770909809075669","article-title":"Forced vital capacity, slow vital capacity, or inspiratory vital capacity: which is the best measure of vital capacity?","volume":"35","author":"Chhabra","year":"1998","journal-title":"J Asthma"},{"key":"10.1016\/j.nmd.2015.11.009_bib0260","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1212\/WNL.52.7.1311","article-title":"Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"52","author":"Miller","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2015.11.009_bib0265","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/17482960601030188","article-title":"A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosis","volume":"8","author":"Mendoza","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nmd.2015.11.009_bib0270","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2015.11.009_bib0275","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ymgme.2011.08.011","article-title":"The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe Registry","volume":"104","author":"Roberts","year":"2011","journal-title":"Mol Genet Metab"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661500797X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661500797X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:10Z","timestamp":1760774650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089661500797X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S096089661500797X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2015.11.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2015.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}